Trial Profile
Evaluation of the efficacy and safety of prulifloxacin vs levofloxacin in the treatment of Chronic Bacterial Prostatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Aug 2021
Price :
$35
*
At a glance
- Drugs Prulifloxacin (Primary) ; Levofloxacin
- Indications Bacterial infections; Prostatitis
- Focus Therapeutic Use
- Sponsors Angelini Group
- 12 May 2021 Status changed from active, no longer recruiting to completed.
- 04 Sep 2020 This trial has been completed in Greece, according to European Clinical Trials Database record.
- 07 Jan 2020 Status changed from recruiting to active, no longer recruiting.